Zurich Cantonal Bank’s Stemline Therapeutics, Inc. STML Stock Holding History

Zurich Cantonal Bank’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,297	Closed	-$21K	–	2652
2020 Q1	$21K	Hold	4,297	–	–	﹤0.01%	2342
2019 Q4	$46K	Hold	4,297	–	–	﹤0.01%	2191
2019 Q3	$45K	Buy	4,297 +1,466	+52%	+$19.2K	﹤0.01%	2117
2019 Q2	$43K	Hold	2,831	–	–	﹤0.01%	2158
2019 Q1	$36K	Buy	+2,831	New	+$32K	﹤0.01%	2190
2017 Q2	–	Sell	-14,000	Closed	-$120K	–	2593
2017 Q1	$120K	Buy	+14,000	New	+$128K	﹤0.01%	1230

Zurich Cantonal Bank's STML Position: Q2 2020 in Review

Zurich Cantonal Bank sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 4,297 shares — an estimated $21K sold.

Zurich Cantonal Bank first reported a position in STML in Q1 2017 and held it in 6 quarters. The position peaked at $120K in Q1 2017. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

Zurich Cantonal Bank reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Zurich Cantonal Bank sold 4,297 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $21K.
Zurich Cantonal Bank first reported a position in Stemline Therapeutics, Inc. in Q1 2017 and held it in 6 quarters.
Zurich Cantonal Bank's Stemline Therapeutics, Inc. position peaked at $120K in Q1 2017.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Zurich Cantonal Bank's 13F filing for Q2 2020, filed 28 Jul 2020.